Annual ROE
-118.13%
-32.95%-38.68%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual return on equity is currently -118.13%, with the most recent change of -32.95% (-38.68%) on 01 December 2023. During the last 3 years, it has fallen by -104.81% (-786.86%). LIPO annual ROE is now -786.86% below its all-time high of -13.32%, reached on 01 December 2020.LIPO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-192.22%
-29.86%-18.39%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly return on equity is currently -192.22%, with the most recent change of -29.86% (-18.39%) on 01 September 2024. Over the past year, it has dropped by -56.24% (-41.36%). LIPO quarterly ROE is now -46.69% below its all-time high of -131.04%, reached on 01 December 2021.LIPO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -41.4% |
| 3 y3 years | -786.9% | -46.7% |
| 5 y5 years | - | - |
LIPO ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -786.9% | +40.3% | -46.7% | +51.7% |
| 5 y | 5 years | -786.9% | +40.3% | -46.7% | +51.7% |
| alltime | all time | -786.9% | +40.3% | -46.7% | +51.7% |
Lipella Pharmaceuticals Common Stock ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -192.22%(+18.4%) |
| June 2024 | - | -162.36%(+1.8%) |
| Mar 2024 | - | -159.49%(+17.3%) |
| Dec 2023 | -118.13%(+38.7%) | -135.98%(-12.7%) |
| Sept 2023 | - | -155.85%(+0.7%) |
| June 2023 | - | -154.71%(+2.5%) |
| Mar 2023 | - | -150.87%(-15.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -85.18%(-56.9%) | -177.70%(-55.3%) |
| Sept 2022 | - | -397.69%(+47.1%) |
| June 2022 | - | -270.27%(+59.3%) |
| Mar 2022 | - | -169.67%(+29.5%) |
| Dec 2021 | -197.73%(+1384.5%) | - |
| Dec 2021 | - | -131.04% |
| Dec 2020 | -13.32% | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual return on equity?
- What is the all time high annual ROE for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly return on equity?
- What is the all time high quarterly ROE for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly ROE year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual return on equity?
The current annual ROE of LIPO is -118.13%
What is the all time high annual ROE for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual return on equity is -13.32%
What is Lipella Pharmaceuticals Common Stock quarterly return on equity?
The current quarterly ROE of LIPO is -192.22%
What is the all time high quarterly ROE for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly return on equity is -131.04%
What is Lipella Pharmaceuticals Common Stock quarterly ROE year-on-year change?
Over the past year, LIPO quarterly return on equity has changed by -56.24% (-41.36%)